Novel oral general anesthetics and metabolitically resistant...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/72 (2006.01) A61K 31/16 (2006.01) A61K 31/275 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/415 (2006.01) A61K 31/4166 (2006.01) A61K 31/45 (2006.01) A61K 31/55 (2006.01) A61K 31/65 (2006.01) A61P 23/00 (2006.01) A61P 25/00 (2006.01) C07C 33/03 (2006.01) C07C 233/05 (2006.01) C07C 235/34 (2006.01) C07D 209/34 (2006.01) C07D 209/36 (2006.01) C07D 209/38 (2006.01) C07D 223/10 (2006.01) C07D 233/02 (2006.01) C07D 233/74 (2006.01) C07D 233/76 (2006.01)

Patent

CA 2443906

The present invention is directed to novel themisone derivative compounds that have been modified to prevent the formation of the toxic metabolite, 2-phenyl- acrylamide. Compositions comprising such derivative compounds have activity as anesthetics and as neuroprotective agents.

La présente invention a trait à des composés dérivés de thémisone qui ont été modifiés en vue d'empêcher la formation du métabolite toxique, 2-phényle-acrylamide. L'invention concerne également des compositions contenant de tels composés dérivés présentant une activité en tant qu'anesthésiques et agents neuroprotecteurs. FIG. 2 : A PHASE I; DONNEES DE LA SOURIS B THEMISOME C INSTITUT NATIONAL DE MALADIES NEUROLOGIQUES ET DE CONGESTION CEREBRALE ; PROGRAMME DE DEVELOPPEMENT D'ANTICONVULSIVANTS D ELECTROCHOC MAXIMAL E DOSAGE (MG/KG) F ANIMAUX PROTEGES G DUREE D'ACTION (HEURES) H ICM-I-40N(17)

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel oral general anesthetics and metabolitically resistant... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel oral general anesthetics and metabolitically resistant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel oral general anesthetics and metabolitically resistant... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1835129

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.